0
0
CHENNAI, India – Dr. Mohan’s Diabetes Specialities Centre has unveiled a groundbreaking development in diabetic eye care, launching India’s first artificial intelligence (AI)-powered software tool designed for the early detection of retinal damage in patients with diabetes. This innovative technology aims to prevent vision loss by enabling accurate diagnosis and timely intervention.
The AI system, which analyzes retinal images using sophisticated algorithms, is designed to identify subtle, early signs of damage characteristic of diabetic retinopathy, a common and potentially blinding complication of diabetes. By detecting these changes sooner than might be possible with traditional methods alone, the tool facilitates proactive treatment strategies.
Initially introduced at the Centre’s clinics in Puducherry and Thanjavur, Dr. Mohan’s plans a nationwide rollout of the AI technology across all 50 of its centres.
Dr. V. Mohan, Chairman of Dr. Mohan’s Diabetes Specialities Centre, emphasized the significant impact of AI, stating it holds a transformative role in the future of healthcare diagnostics and patient management.
Highlighting the clinical importance of the new tool, Dr. R. M. Anjana, Managing Director, stressed that early detection is paramount in preventing the progression of diabetic retinopathy and preserving vision in individuals living with diabetes.
The launch represents a significant step in integrating advanced technology into routine diabetes care in India, potentially improving outcomes for millions affected by the condition.
Disclaimer: This news article is based solely on the information provided in the text snippet referencing a report from The Hindu. It reflects the details mentioned regarding the launch of the AI tool by Dr. Mohan’s Diabetes Specialities Centre.
